168 related articles for article (PubMed ID: 24667739)
1. Rescue of the Friedreich ataxia knockout mutation in transgenic mice containing an FXN-EGFP genomic reporter.
Sarsero JP; Holloway TP; Li L; Finkelstein DI; Ioannou PA
PLoS One; 2014; 9(3):e93307. PubMed ID: 24667739
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia.
Li L; Voullaire L; Sandi C; Pook MA; Ioannou PA; Delatycki MB; Sarsero JP
PLoS One; 2013; 8(2):e55940. PubMed ID: 23418481
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an FRDA-EGFP genomic reporter assay in transgenic mice.
Sarsero JP; Holloway TP; Li L; McLenachan S; Fowler KJ; Bertoncello I; Voullaire L; Gazeas S; Ioannou PA
Mamm Genome; 2005 Apr; 16(4):228-41. PubMed ID: 15965784
[TBL] [Abstract][Full Text] [Related]
4. A GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds.
Lufino MM; Silva AM; Németh AH; Alegre-Abarrategui J; Russell AJ; Wade-Martins R
Hum Mol Genet; 2013 Dec; 22(25):5173-87. PubMed ID: 23943791
[TBL] [Abstract][Full Text] [Related]
5. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
[TBL] [Abstract][Full Text] [Related]
6. Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice.
Sarsero JP; Li L; Holloway TP; Voullaire L; Gazeas S; Fowler KJ; Kirby DM; Thorburn DR; Galle A; Cheema S; Koenig M; Williamson R; Ioannou PA
Mamm Genome; 2004 May; 15(5):370-82. PubMed ID: 15170226
[TBL] [Abstract][Full Text] [Related]
7. Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia.
Soragni E; Herman D; Dent SY; Gottesfeld JM; Wells RD; Napierala M
Nucleic Acids Res; 2008 Nov; 36(19):6056-65. PubMed ID: 18820300
[TBL] [Abstract][Full Text] [Related]
8. Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.
Medina-Carbonero M; Sanz-Alcázar A; Britti E; Delaspre F; Cabiscol E; Ros J; Tamarit J
Cell Mol Life Sci; 2022 Jan; 79(2):74. PubMed ID: 35038030
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
Sarsero JP; Li L; Wardan H; Sitte K; Williamson R; Ioannou PA
J Gene Med; 2003 Jan; 5(1):72-81. PubMed ID: 12516053
[TBL] [Abstract][Full Text] [Related]
10. Neurobehavioral deficits of mice expressing a low level of G127V mutant frataxin.
Fil D; Conley RL; Zuberi AR; Lutz CM; Gemelli T; Napierala M; Napierala JS
Neurobiol Dis; 2023 Feb; 177():105996. PubMed ID: 36638893
[TBL] [Abstract][Full Text] [Related]
11. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
[TBL] [Abstract][Full Text] [Related]
12. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
[TBL] [Abstract][Full Text] [Related]
13. A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.
Evans-Galea MV; Corben LA; Hasell J; Galea CA; Fahey MC; du Sart D; Delatycki MB
Neurogenetics; 2011 Nov; 12(4):307-13. PubMed ID: 21830088
[TBL] [Abstract][Full Text] [Related]
14. Long range regulation of human FXN gene expression.
Puspasari N; Rowley SM; Gordon L; Lockhart PJ; Ioannou PA; Delatycki MB; Sarsero JP
PLoS One; 2011; 6(7):e22001. PubMed ID: 21760943
[TBL] [Abstract][Full Text] [Related]
15. Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia.
Anjomani Virmouni S; Sandi C; Al-Mahdawi S; Pook MA
PLoS One; 2014; 9(9):e107416. PubMed ID: 25198290
[TBL] [Abstract][Full Text] [Related]
16. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
Liu J; Verma PJ; Evans-Galea MV; Delatycki MB; Michalska A; Leung J; Crombie D; Sarsero JP; Williamson R; Dottori M; Pébay A
Stem Cell Rev Rep; 2011 Sep; 7(3):703-13. PubMed ID: 21181307
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia.
Galea CA; Huq A; Lockhart PJ; Tai G; Corben LA; Yiu EM; Gurrin LC; Lynch DR; Gelbard S; Durr A; Pousset F; Parkinson M; Labrum R; Giunti P; Perlman SL; Delatycki MB; Evans-Galea MV
Ann Neurol; 2016 Mar; 79(3):485-95. PubMed ID: 26704351
[TBL] [Abstract][Full Text] [Related]
19. Expression of human frataxin is regulated by transcription factors SRF and TFAP2.
Li K; Singh A; Crooks DR; Dai X; Cong Z; Pan L; Ha D; Rouault TA
PLoS One; 2010 Aug; 5(8):e12286. PubMed ID: 20808827
[TBL] [Abstract][Full Text] [Related]
20. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
